Sonic Healthcare Ltd. Sponsored ADR (OTCMKTS:SKHHY – Get Free Report) saw unusually-high trading volume on Thursday . Approximately 205,423 shares were traded during mid-day trading, an increase of 89% from the previous session’s volume of 108,823 shares.The stock last traded at $14.32 and had previously closed at $14.58.
Analyst Upgrades and Downgrades
Separately, Zacks Research lowered shares of Sonic Healthcare from a “hold” rating to a “strong sell” rating in a research report on Wednesday. Two equities research analysts have rated the stock with a Sell rating, According to MarketBeat.com, the company presently has a consensus rating of “Sell”.
Read Our Latest Report on SKHHY
Sonic Healthcare Trading Up 3.6%
Sonic Healthcare Company Profile
Sonic Healthcare (OTCMKTS:SKHHY) is a global provider of medical diagnostics services, specializing in pathology and radiology. Established in 1987 and headquartered in Sydney, Australia, the company has grown into one of the largest laboratory networks in the world. Its ordinary shares trade on the Australian Securities Exchange, and its American Depositary Receipts trade over the counter under the symbol SKHHY.
The company offers a broad range of clinical pathology services, including anatomic pathology, clinical chemistry, hematology, microbiology and molecular diagnostics.
Further Reading
- Five stocks we like better than Sonic Healthcare
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for Sonic Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonic Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
